Can I take metoclopramide (Reglan) one hour after glasdegib (Vonquenza)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can You Take Reglan One Hour Post Vonquenza?

Yes, you can take metoclopramide (Reglan) one hour after vonoprazan (Vonquenza), but be aware that both drugs carry a risk of QT prolongation, which requires monitoring if you have cardiac risk factors.

Key Drug Interaction Considerations

QT Prolongation Risk

Both vonoprazan and metoclopramide can prolong the QT interval, though this is generally a rare adverse effect. The primary concern is additive QT prolongation when these medications are used together 1.

Specific risk factors that warrant caution:

  • Pre-existing QT prolongation or congenital long QT syndrome
  • Electrolyte disturbances (hypokalemia, hypomagnesemia, hypocalcemia)
  • Concurrent use of other QT-prolonging medications
  • Cardiac rhythm disorders
  • Advanced age

No Direct Pharmacokinetic Interaction

There is no evidence of direct pharmacokinetic interaction between vonoprazan and metoclopramide:

  • Vonoprazan metabolism: Primarily metabolized by CYP3A4/5 2
  • Metoclopramide metabolism: Different metabolic pathway (N-4 sulfate conjugation) 3
  • Timing: The one-hour separation you're proposing is adequate from an absorption standpoint, as vonoprazan can be taken with or without food and has rapid absorption 2

Clinical Recommendations

When This Combination Is Appropriate

  • Nausea management: Metoclopramide is commonly used as adjunctive therapy for nausea, including in patients taking acid-suppressing medications 4
  • Standard dosing: Metoclopramide 10 mg orally is the typical dose for nausea 4
  • No dose adjustment needed: Neither drug requires dose modification based solely on concurrent use

Monitoring Requirements

If you have cardiac risk factors, obtain:

  • Baseline ECG before starting this combination
  • Serum electrolytes (potassium, magnesium, calcium)
  • Follow-up ECG if symptoms develop (palpitations, dizziness, syncope)

For routine use without cardiac risk factors:

  • Standard monitoring is generally sufficient
  • Be alert for symptoms of QT prolongation (irregular heartbeat, dizziness, lightheadedness)

Important Caveats

Duration of Metoclopramide Use

Limit metoclopramide to short-term use (typically days to weeks, not months) to minimize:

  • Risk of tardive dyskinesia with prolonged use
  • Cumulative QT prolongation risk
  • Other neurological side effects 4

Alternative Antiemetics

If you have significant cardiac risk factors or are already on multiple QT-prolonging drugs, consider alternative antiemetics that don't prolong QT interval, such as:

  • H1 antihistamines (meclizine, dimenhydrinate)
  • Anticholinergics (scopolamine)

Bottom Line

The one-hour separation between vonoprazan and metoclopramide is clinically appropriate. The main concern is not the timing or absorption interaction, but rather the additive risk of QT prolongation in susceptible individuals. For most patients without cardiac risk factors, this combination can be used safely with standard monitoring. If you have heart disease, electrolyte abnormalities, or take other QT-prolonging medications, discuss ECG monitoring with your healthcare provider before combining these drugs 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.